200 related articles for article (PubMed ID: 29127647)
1. O-GlcNAcylation in women's cancers: breast, endometrial and ovarian.
Trinca GM; Hagan CR
J Bioenerg Biomembr; 2018 Jun; 50(3):199-204. PubMed ID: 29127647
[TBL] [Abstract][Full Text] [Related]
2. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
3. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.
Ma Z; Vosseller K
J Biol Chem; 2014 Dec; 289(50):34457-65. PubMed ID: 25336642
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation in health and neurodegenerative diseases.
Lee BE; Suh PG; Kim JI
Exp Mol Med; 2021 Nov; 53(11):1674-1682. PubMed ID: 34837015
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
6. New insights: A role for O-GlcNAcylation in diabetic complications.
Peterson SB; Hart GW
Crit Rev Biochem Mol Biol; 2016; 51(3):150-61. PubMed ID: 26806492
[TBL] [Abstract][Full Text] [Related]
7. Roles of O-GlcNAc in chronic diseases of aging.
Banerjee PS; Lagerlöf O; Hart GW
Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471
[TBL] [Abstract][Full Text] [Related]
8. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAc signaling in cancer metabolism and epigenetics.
Singh JP; Zhang K; Wu J; Yang X
Cancer Lett; 2015 Jan; 356(2 Pt A):244-50. PubMed ID: 24769077
[TBL] [Abstract][Full Text] [Related]
10. T cell development and the physiological role of O-GlcNAc.
Abramowitz LK; Hanover JA
FEBS Lett; 2018 Dec; 592(23):3943-3949. PubMed ID: 29904918
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of O-GlcNAcylated proteins in invasive ductal breast carcinomas with and without lymph node metastasis.
Jiang K; Gao Y; Hou W; Tian F; Ying W; Li L; Bai B; Hou G; Wang PG; Zhang L
Amino Acids; 2016 Feb; 48(2):365-74. PubMed ID: 26374642
[TBL] [Abstract][Full Text] [Related]
12. Potential coordination role between O-GlcNAcylation and epigenetics.
Wu D; Cai Y; Jin J
Protein Cell; 2017 Oct; 8(10):713-723. PubMed ID: 28488246
[TBL] [Abstract][Full Text] [Related]
13. High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.
Tiainen S; Oikari S; Tammi M; Rilla K; Hämäläinen K; Tammi R; Kosma VM; Auvinen P
Breast Cancer Res Treat; 2016 Nov; 160(2):237-247. PubMed ID: 27683279
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
Harosh-Davidovich SB; Khalaila I
Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
[TBL] [Abstract][Full Text] [Related]
15. Distributive O-GlcNAcylation on the Highly Repetitive C-Terminal Domain of RNA Polymerase II.
Lu L; Fan D; Hu CW; Worth M; Ma ZX; Jiang J
Biochemistry; 2016 Feb; 55(7):1149-58. PubMed ID: 26807597
[TBL] [Abstract][Full Text] [Related]
16. Modulation of transcription factor function by O-GlcNAc modification.
Ozcan S; Andrali SS; Cantrell JE
Biochim Biophys Acta; 2010; 1799(5-6):353-64. PubMed ID: 20202486
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAc: a regulatory post-translational modification.
Wells L; Whelan SA; Hart GW
Biochem Biophys Res Commun; 2003 Mar; 302(3):435-41. PubMed ID: 12615051
[TBL] [Abstract][Full Text] [Related]
18. A novel strategy for global mapping of O-GlcNAc proteins and peptides using selective enzymatic deglycosylation, HILIC enrichment and mass spectrometry identification.
Shen B; Zhang W; Shi Z; Tian F; Deng Y; Sun C; Wang G; Qin W; Qian X
Talanta; 2017 Jul; 169():195-202. PubMed ID: 28411811
[TBL] [Abstract][Full Text] [Related]
19. Minireview series on the thirtieth anniversary of research on O-GlcNAcylation of nuclear and cytoplasmic proteins: Nutrient regulation of cellular metabolism and physiology by O-GlcNAcylation.
Hart GW
J Biol Chem; 2014 Dec; 289(50):34422-3. PubMed ID: 25336646
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
Hanover JA; Chen W; Bond MR
J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
